Element Squared »

Halozyme Therapeutics shares owned by Element Squared

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Element Squared from 13F filings

Historical chart of Element Squared investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Element Squared consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Element Squared

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.2M 18k 67.30

More positions owned by Element Squared

Innovator Etfs Trust Grwt100 Pwr Buf (NOCT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
NVIDIA Corporation (NVDA)
Innovator Etfs Trust Growth 100 Pwr B (NNOV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Innovator Etfs Trust Us Eqty Pwr Buf (PJAN)
Amphenol Corp Cl A (APH)
Alphabet Cap Stk Cl A (GOOGL)
Parker-Hannifin Corporation (PH)
Advanced Micro Devices (AMD)
Applovin Corp Com Cl A (APP)
Broadcom (AVGO)
Biogen Idec (BIIB)

View all positions for Element Squared

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Invesco
Arrowstreet Capital, Limited Partnership
D. E. Shaw & Co
Geode Capital Management
Snyder Capital Management
Dimensional Fund Advisors
Alliancebernstein
Norges Bank Investment Management
William Blair Investment Management
Federated Investors
Jupiter Asset Management
Wells Fargo & Company

View all funds holding Halozyme Therapeutics